Allergy and Immunology · Okemos, MI
NPI
1821295213
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3955 Okemos Rd, Ste A1
Okemos, MI, 48864
Phone (517) 349-0027
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
4,309 services
Medicare patients, 2024
146
Average age 69
Drug cost, 2024
$851K
1,739 prescriptions
Company payments, 2025
$1,763
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manoj Mohan was code 95004 (test - miscellaneous), 1,711 times for 34 patients. In total Manoj Mohan billed 4,309 services in 27 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,711 | 34 | $2.59 | $4,429 |
| 95165 Treatment - Miscellaneous | Office | 1,472 | 27 | $9.72 | $14K |
| 95117 Treatment - Miscellaneous | Office | 350 | 24 | $8.00 | $2,799 |
| 95024 Test - Miscellaneous | Office | 233 | 28 | $5.60 | $1,306 |
| 99213 Office E&M - Established | Office | 93 | 73 | $62.09 | $5,774 |
| 94010 Pulmonary Function Testing | Office | 71 | 49 | $18.85 | $1,338 |
| 99214 Office E&M - Established | Office | 55 | 43 | $86.42 | $4,753 |
| 99203 Office E&M - New | Office | 38 | 38 | $74.68 | $2,838 |
| 95012 Pulmonary | Office | 24 | 19 | $11.89 | $285 |
By year: 2022 $95K for 5,417 services; 2023 $34K for 3,188 services; 2024 $41K for 4,309 services.
Medicare prescription drug claims, 2024
In 2024, the drug Manoj Mohan prescribed most often to Medicare patients was Montelukast Sodium, with 348 prescriptions and refills. In total Manoj Mohan wrote 1,739 Medicare prescriptions that cost $851K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 348 | 896 | 113 | $6,769 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 126 | 262 | 39 | $161K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 120 | 150 | 88 | $5,401 |
| Fluticasone Propionate Generic | 109 | 272 | 57 | $3,142 |
| Levocetirizine Dihydrochloride Generic | 98 | 256 | 37 | $1,746 |
| Azelastine Hcl Generic | 89 | 218 | 44 | $3,388 |
| Breo Ellipta Fluticasone/Vilanterol | 60 | 126 | 22 | $48K |
| Arnuity Ellipta Fluticasone Furoate | 57 | 92 | 17 | $21K |
| Prednisone Generic | 54 | 54 | 44 | $110 |
| Epinephrine Generic | 53 | 57 | 40 | $16K |
| Ipratropium Bromide Generic | 40 | 85 | 24 | $1,952 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 36 | 79 | 14 | $9,096 |
| Symbicort Budesonide/Formoterol Fumarate | 34 | 83 | 15 | $15K |
| Ryaltris Olopatadine Hcl/Mometasone | 30 | 53 | Under 11 | $11K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 20 | $293 |
Brand drugs: 652 claims; generic drugs: 1,087 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manoj Mohan $1,763 ($1,763 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $346.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $346 |
| GlaxoSmithKline, LLC. GSK | 13 | $229 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $176 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 7 | $161 |
| Genentech USA, Inc. ROG.SW | 6 | $148 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $129 |
| Organon LLC OGN | 7 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $89.94 |
| Amgen Inc. AMGN | 5 | $83.86 |
| CSL Behring CSL.AX | 3 | $76.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.